PVP Ventures Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

PVP Ventures has announced a board meeting on the approval of the financial results for the year ended March 31, 2025. Consolidated revenue jumped to Rs. 38.61 Cr from Rs. 16.80 Cr, led by real estate contributions of Rs. 17.02 Cr standalone. Despite this, the group posted a consolidated net loss of Rs. 8.56 Cr, weighed down by a Rs. 6.70 Cr impairment loss at its healthcare subsidiary Humain Health Tech (HHT). Key moves: acquisition of 56% stake in Optimus Oncology for Rs. 54.73 lakh; merger of HHT with the parent effective April 2024; Rs. 150 Cr raised via secured NCDs; sale of NCCPL for Rs. 32.56 Cr. Management is focused on turning around healthcare and monetizing real estate assets amid ongoing restructuring. Consolidated EPS loss stood at Rs. 0.26 per share.